NDC 51224-102
Hydromorphone Hydrochloride
Hydromorphone Hydrochloride
Hydromorphone Hydrochloride is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Tagi Pharma, Inc.. The primary component is Hydromorphone Hydrochloride.
| Product ID | 51224-102_c0c7ee11-92a1-48e7-8861-b4c3d5d0232a |
| NDC | 51224-102 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Hydromorphone Hydrochloride |
| Generic Name | Hydromorphone Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-03-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA076723 |
| Labeler Name | TAGI Pharma, Inc. |
| Substance Name | HYDROMORPHONE HYDROCHLORIDE |
| Active Ingredient Strength | 8 mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |